Recombinant Anti-ADAM15 Antibody, Rabbit Monoclonal sinobiological 10517-R007

$1,900.00
In stock
SKU
10517-R007
Catalog No.SizePrice (USD)
10517-R007-11 mL$1,969.87
10517-R007-2020 µL$118.49
10517-R007-5050 µL$177.58
10517-R007-100100 µL$340.51

General Information

Product nameRecombinant Anti-ADAM15 Antibody, Rabbit Monoclonal
Validated applicationsELISA (FAQ Protocol), ELISA(Det) (FAQ Protocol), IHC-P (FAQ Protocol), FCM (FAQ Protocol), ICC/IF (FAQ Protocol)
Species reactivityReacts with: Human
SpecificityHuman ADAM15
ImmunogenRecombinant Human ADAM15 protein (Catalog#10517-H08H)
PreparationThis antibody was obtained from a rabbit immunized with purified, recombinant Human ADAM15 (rh ADAM15; Catalog#10517-H08H; NP_997074.1; Met 1-Thr 696).
SourceMonoclonal Rabbit IgG Clone #007
PurificationProtein A
Formulation0.2 μm filtered solution in PBS
ConjugateUnconjugated
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageThis antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Synonyms: Anti-MDC15 Antibody

Image / Experimental Information

Image 1 DescriptionProfile of anti-ADAM15 reactivity on MCF-7 cells analyzed by flow cytometry.
Image 1 Alt TextHuman ADAM15 Flow Cytometry (FC) 2645
Image 1 URLSource image
Image 2 DescriptionProfile of anti-ADAM15 reactivity on MCF-7 cells analyzed by flow cytometry.
Image 2 Alt TextHuman ADAM15 Immunohistochemistry(IHC) 2721
Image 2 URLSource image
Image 3 DescriptionProfile of anti-ADAM15 reactivity on MCF-7 cells analyzed by flow cytometry.
Image 3 Alt TextHuman ADAM15 Immunohistochemistry(IHC) 2729
Image 3 URLSource image
Image 4 DescriptionProfile of anti-ADAM15 reactivity on MCF-7 cells analyzed by flow cytometry.
Image 4 Alt TextHuman Fetuin-A Immunofluorescence(IF) 3018
Image 4 URLSource image

Background Information

Full NameADAM metallopeptidase domain 15
DescriptionADAM15, also known as Metargidin, is a type I transmembrane glycoprotein belonging to the ADAM (A Disintegrin and Metalloprotease Domain) family of proteins and is widely expressed in different tissues and cell types. Members of this family contain an amino-terminal metalloprotease domain followed by a disintegrin domain, a cysteine-rich region and a membrane proximal EGF-like domain. The disintegrin domain of ADAM15/metargidin contains an RGD tripeptide sequence, suggesting that it may potentially interact with the integrin family of proteins. ADAM15 is a transmembrane multi-domain proteins implicated in proteolysis, cell-cell and cell-matrix interactions in various disease conditions. There is also evidence supporting a role for ADAM15 in angiogenesis and angioinvasion of tumor cells, which are critical for unrestrained tumor growth and metastatic spread. Given its diverse functions, ADAM15 may represent a pivotal regulatory component of tumor progression, an important target for therapeutic intervention, or emerge as a biomarker of disease progression.
Related Pathways
  • Notch Signaling
References
  1. Poghosyan Z, et al. (2002) Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases. J Biol Chem. 277(7): 4999-5007.
  2. Carl-McGrath S, et al. (2005) The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. Int J Oncol. 26(1): 17-24.
  3. Najy AJ, et al. (2008) ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction. Cancer Res. 68(4): 1092-9.
  4. Maretzky T, et al. (2009) Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays. Biochem J. 420(1): 105-13.

Reviews

Write Your Own Review
You're reviewing:Recombinant Anti-ADAM15 Antibody, Rabbit Monoclonal sinobiological 10517-R007
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.